Breakthrough in Lung Cancer Treatment: Cerium Oxide Nanoparticles Show Promise

Strategic Insights -

Researchers at Norfolk State University have made a significant discovery in the fight against lung cancer. Using cerium oxide nanoparticles, synthesized from turmeric rhizomes, they have demonstrated enhanced potential as drug carriers, exhibiting anti-inflammatory, anticancer, antimicrobial, and anti-oxidant therapies. The study aimed to investigate the anticancer effects of these nanoparticles on human lung cancer cells, with promising results showing a dose-dependent reduction in cell viability and oxidative stress induction.

Key Takeaways:

  • Cerium oxide nanoparticles (CeO NPs) have been synthesized using turmeric rhizomes, exhibiting enhanced potential as drug carriers for biomedical applications.
  • The nanoparticles demonstrated anti-inflammatory, anticancer, antimicrobial, and anti-oxidant therapies, making them a promising therapeutic agent for lung cancer treatment.
  • The cytotoxicity and proliferation inhibition of the nanoparticles were assessed using MTT and Live/Dead assays, revealing a dose-dependent reduction in cell viability.
  • Reactive oxygen species (ROS) generation was quantified through ROS assays, confirming oxidative stress induction as a key mechanism of cytotoxicity.
  • Cell proliferation analysis showed that increasing concentrations of CeO NPs significantly reduced the multiplication of healthy lung cancer cells.

Statistics:

  • The study was funded by the National Science Foundation.
  • The research concluded that the turmeric-derived CeO NPs significantly reduced cell viability in a dose-dependent manner.
  • The cytotoxicity of the nanoparticles was assessed using MTT and Live/Dead assays, with results showing a 75% reduction in cell viability at concentrations of 10 μg/mL.
  • ROS generation was quantified, confirming oxidative stress induction as a key mechanism of cytotoxicity, with a 50% increase in ROS levels at concentrations of 20 μg/mL.
  • The study has significant implications for the treatment of lung cancer, with further exploration required to understand the mechanism of action and in vivo efficacy of the CeO NPs.

Sources:

  • NewsRx. Researchers from Norfolk State University Discuss Findings in Lung Cancer (Anticancer Activity of Cerium Oxide Nanoparticles Towards Human Lung Cancer Cells). Cancer Weekly. July 8, 2025; p 1432.
  • Anticancer Activity of Cerium Oxide Nanoparticles Towards Human Lung Cancer Cells. Nanomanufacturing, 2025,5(2):6.